Summary
- Current Price
- As of today, CADL price is $8.35, up +7.19% on
- Current Price All-Time High
- CADL price is currently -43.50% below its historical high of $14.78 set on
- Market Cap
- CADL current market cap is $612M, up +156.53% over the past 365 days
- PE Ratio
- CADL PE ratio is unknown
- Revenue
- CADL current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CADL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Candel Therapeutics, Inc. |
| Ticker | NASDAQ: CADL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | candeltx.com |
| Employees | 38 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $8.35 | ||
| Price, 1D Change | +7.19% | |
| $612M | ||
| - | ||
| - | ||
| 2.14 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.72 | ||
| EPS, 1Y Change | +58.61% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.72 | ||
| EPS Estimate | N/A | -$0.77 |
| EPS Est. Change | N/A | -6.80% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $8.35 | ||
| Price Target | - | $19.50 |
| Price Tgt. Change | - | +133.53% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.14 | -$1.74 | -52.33% | |
| -$0.63 | -$0.72 | -15.36% | |
| -$0.77 | N/A | -6.80% | |
| -$0.64 | N/A | +11.23% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $46.83M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +75.42% | ||
| +409.15% | ||
| +156.53% | ||
| +1,189.96% | ||
| 0.00% | ||
| -100.00% | ||
| +58.61% | ||
| -10.58% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $8.35 | ||
| $5.58 | ||
| SMA 200 vs Price | -33.17% | |
| $5.61 | ||
| SMA 50 vs Price | -32.81% | |
| 2.14 | ||
| $0.48 | ||
| 76.50 | ||
| 90.32% | ||
| 73.88% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.72 | ||
| -$845.00K | ||
| - | ||
| -$48.27M | ||
| - | ||
| -$38.18M | ||
| - | ||
| -$47.42M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.94 | ||
| 13.49 | ||
| 13.49 | ||
| - | ||
| - | ||
| 2.22 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 11.78 | ||
| -11.41 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $51.92M | ||
| $119.73M | ||
| $125.63M | ||
| $121.39M | ||
| $73.71M | ||
| $9.00M | ||
| $49.03M | ||
| $445.00K | ||
| $1.13M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $38.18M | ||
| $47.42M | ||
| $845.00K | ||
| $0.00 | ||
| $845.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$38.31M | ||
| -$560.00K | ||
| $56.10M | ||
| $587.00K | ||
| -$38.90M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Cantor Fitzgerald | ||
| Citigroup | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| Stephens & Co. | → | |
| Freedom Broker | → | |
| Citigroup | → | |
| Stephens & Co. | ||
| LifeSci Capital | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with CADL
FAQ
What is the ticker symbol for Candel Therapeutics, Inc.?
The ticker symbol for Candel Therapeutics, Inc. is NASDAQ:CADL
Does Candel Therapeutics, Inc. pay dividends?
No, Candel Therapeutics, Inc. does not pay dividends
What sector is Candel Therapeutics, Inc. in?
Candel Therapeutics, Inc. is in the Healthcare sector
What industry is Candel Therapeutics, Inc. in?
Candel Therapeutics, Inc. is in the Biotechnology industry
What country is Candel Therapeutics, Inc. based in?
Candel Therapeutics, Inc. is headquartered in United States
When did Candel Therapeutics, Inc. go public?
Candel Therapeutics, Inc. initial public offering (IPO) was on July 27, 2021
Is Candel Therapeutics, Inc. in the S&P 500?
No, Candel Therapeutics, Inc. is not included in the S&P 500 index
Is Candel Therapeutics, Inc. in the NASDAQ 100?
No, Candel Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Candel Therapeutics, Inc. in the Dow Jones?
No, Candel Therapeutics, Inc. is not included in the Dow Jones index
When was Candel Therapeutics, Inc. last earnings report?
Candel Therapeutics, Inc.'s most recent earnings report was on March 12, 2026
When does Candel Therapeutics, Inc. report earnings?
The next expected earnings date for Candel Therapeutics, Inc. is May 12, 2026
Data Sources & References
- CADL Official Website www.candeltx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1841387/000119312526103134/0001193125-26-103134-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1841387/000119312526103134/0001193125-26-103134-index.htm
- CADL Profile on Yahoo Finance finance.yahoo.com/quote/CADL
- CADL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cadl